{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:47:56Z","timestamp":1781671676609,"version":"3.54.5"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>The decline in circulating estrogen levels in peri- and postmenopause has a wide range of physiological effects, including atrophy of tissues in the urogenital tract. Vaginal atrophy is an important contributor to postmenopausal sexual dysfunction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To provide a framework for clinical evaluation and clinical management of sexual dysfunction secondary to vaginal atrophy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>Conduct a brief overview of literature on evaluation and treatment of vaginal atrophy, augmented with the authors\u2019 clinical observations and experience.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Estrogen decline disrupts many physiological responses characteristic of sexual arousal, including smooth muscle relaxation, vasocongestion, and vaginal lubrication; genital tissues depend on continued estrogen and androgen stimulation for normal function. An upward shift in vaginal pH as the result of vaginal atrophy alters the normal vaginal flora. Reduced lubrication capability and reduced tissue elasticity, in addition to shortening and narrowing of the vaginal vault, can lead to painful and\/or unpleasant intercourse. At the same time, diminished sensory response may reduce orgasmic intensity. Other contributors to peri- and postmenopausal sexual dysfunction include reduced androgen levels, aging of multiple body systems, and side-effects of medications. Workup of sexual health problems starts by taking a comprehensive sexual, medical, and psychosocial history, followed by complete physical examination and laboratory evaluation. Clinical management includes measures to preserve and enhance overall health, adjustment of medication regimes to reduce or avoid side-effects, and topical or systemic hormone supplementation with estrogens and\/or androgens.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>No single therapeutic approach is appropriate for every woman with peri- or postmenopausal sexual dysfunction; instead, treatment should be based on a comprehensive evaluation and consideration of medical and psychosocial contributors to the individual's dysfunction. Further research is required to establish optimal regimens of hormonal and nonhormonal agents, including dosages\/dosage forms and duration of treatment, for specific subtypes of sexual dysfunction.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2005.00131.x","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T10:35:13Z","timestamp":1123842913000},"page":"154-165","source":"Crossref","is-referenced-by-count":103,"title":["Practical Aspects in the Management of Vaginal Atrophy and Sexual Dysfunction in Perimenopausal and Postmenopausal Women"],"prefix":"10.1093","volume":"2","author":[{"given":"Irwin","family":"Goldstein","sequence":"first","affiliation":[{"name":"Journal of Sexual Medicine , Milton,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne Leventhal","family":"Alexander","sequence":"additional","affiliation":[{"name":"Kaiser Permanente , Berkeley , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,9,1]]},"reference":[{"key":"2024032600050522700_bib1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/15409990260363661","article-title":"Quality of life and menopause: The role of estrogen","volume":"11","author":"Freedman","year":"2002","journal-title":"J Womens Health (Larchmt)"},{"key":"2024032600050522700_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/jama.281.6.537","article-title":"Sexual dysfunction in the United States: Prevalence and predictors","volume":"281","author":"Laumann","year":"1999","journal-title":"JAMA"},{"issue":"suppl 4","key":"2024032600050522700_bib3","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0015-0282(02)03001-7","article-title":"Hormones, mood, sexuality, and the menopausal transition","volume":"77","author":"Dennerstein","year":"2002","journal-title":"Fertil Steril"},{"key":"2024032600050522700_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1743-6109.2004.10106.x","article-title":"Epidemiology\/risk factors of sexual dysfunction","volume":"1","author":"Lewis","year":"2004","journal-title":"J Sex Med"},{"key":"2024032600050522700_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1743-6109.2004.10108.x","article-title":"Clinical evaluation and management strategy for sexual dysfunction in men and women","volume":"1","author":"Hatzichristou","year":"2004","journal-title":"J Sex Med"},{"key":"2024032600050522700_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1743-6109.2004.10112.x","article-title":"Endocrine aspects of female sexual dysfunction","volume":"1","author":"Davis","year":"2004","journal-title":"J Sex Med"},{"key":"2024032600050522700_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1743-6109.2005.20102.x","article-title":"Clinical biologic pathophysiologies of women's sexual dysfunction","volume":"2","author":"Nappi","year":"2005","journal-title":"J Sex Med"},{"key":"2024032600050522700_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1743-6109.2005.20356.x","article-title":"The impact of aging on sexual function and sexual dysfunction in women: A review of population based studies","volume":"2","author":"Hayes","year":"2005","journal-title":"J Sex Med"},{"key":"2024032600050522700_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1743-6109.2004.10105.x","article-title":"Summary of the recommendations on sexual dysfunctions in women","volume":"1","author":"Basson","year":"2004","journal-title":"J Sex Med"},{"key":"2024032600050522700_bib10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1743-6109.2005.20346.x","article-title":"Assessment and management of women's sexual dysfunctions: Problematic desire and arousal","volume":"2","author":"Basson","year":"2005","journal-title":"J Sex Med"},{"issue":"suppl 1","key":"2024032600050522700_bib11","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1038\/sj.ijir.3900800","article-title":"The role of the partner in erectile dysfunction and its treatment","volume":"14","author":"Riley","year":"2002","journal-title":"Int J Impot Res"},{"key":"2024032600050522700_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1701-2163(16)30662-4","article-title":"The detection and management of vaginal atrophy","volume":"26","author":"Johnston","year":"2004","journal-title":"Obstet Gynaecol Can"},{"key":"2024032600050522700_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.maturitas.2004.04.007","article-title":"Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy","volume":"50","author":"Palacios","year":"2005","journal-title":"Maturitas"},{"key":"2024032600050522700_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1743-6109.04037.x","article-title":"Physiology of female sexual function: Animal models","volume":"1","author":"Giraldi","year":"2004","journal-title":"J Sex Med"},{"issue":"suppl 3","key":"2024032600050522700_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1743-6109.2005.00129.x","article-title":"Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition","volume":"2","author":"Graziottin","year":"2005","journal-title":"J Sex Med"},{"key":"2024032600050522700_bib16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","article-title":"Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate","volume":"75","author":"Utian","year":"2001","journal-title":"Fertil Steril"},{"key":"2024032600050522700_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0301-2115(96)02612-7","article-title":"Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy","volume":"71","author":"Barentsen","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2024032600050522700_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5122(03)00240-8","article-title":"Low-dose (0.3 mg) synthetic conjugated estrogens A is effective for managing atrophic vaginitis","volume":"47","author":"Marx","year":"2004","journal-title":"Maturitas"},{"key":"2024032600050522700_bib19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.fertnstert.2005.01.119","article-title":"The relative effects of hormones and relationship factors on sexual functioning of women through the natural menopausal transition","volume":"84","author":"Dennerstein","year":"2005","journal-title":"Fertil Steril"},{"key":"2024032600050522700_bib20","first-page":"1","article-title":"Hormones & female sexual dysfunction in postmenopausal women","volume":"12","author":"Kovalevsky","year":"2004","journal-title":"Menopausal Med"},{"key":"2024032600050522700_bib21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/sj.ijir.3900998","article-title":"Does sexual dysfunction correlate with deterioration of somatic sensory system in diabetic women?","volume":"15","author":"Erol","year":"2003","journal-title":"Int J Impot Res"},{"issue":"suppl 1","key":"2024032600050522700_bib22","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1089\/152460900318830","article-title":"Effects of hormone replacement therapy on sexual psychophysiology and behavior in postmenopause","volume":"9","author":"Sarrel","year":"2000","journal-title":"J Womens Health Gend Based Med"},{"issue":"6 Part 2","key":"2024032600050522700_bib23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.GME.0000142887.31811.97","article-title":"The effects of postmenopausal hormone therapies on female sexual functioning: A review of double-blind, randomized controlled trials","volume":"11","author":"Alexander","year":"2004","journal-title":"Menopause"},{"key":"2024032600050522700_bib24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/01.AOG.0000158103.27672.0d","article-title":"Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial","volume":"105","author":"Buster","year":"2005","journal-title":"Obstet Gynecol"},{"key":"2024032600050522700_bib25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1530\/eje.1.01907","article-title":"Health status in patients with sub-clinical hypothyroidism","volume":"152","author":"Razvi","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2024032600050522700_bib26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00004714-198606000-00004","article-title":"Effects of antidepressant medication on sexual function: A controlled study","volume":"6","author":"Harrison","year":"1986","journal-title":"J Clin Psychopharmacol"},{"issue":"suppl 3","key":"2024032600050522700_bib27","first-page":"10","article-title":"Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1,022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction","volume":"62","author":"Montejo","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"2024032600050522700_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4088\/JCP.v63n0414","article-title":"Prevalence of sexual dysfunction among newer antidepressants","volume":"63","author":"Clayton","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"2024032600050522700_bib29","first-page":"476","article-title":"Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline","volume":"61","author":"Model","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"suppl 16","key":"2024032600050522700_bib30","first-page":"26","article-title":"The burden of disease for treatment-resistant depression","volume":"62","author":"Greden","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"2024032600050522700_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/10401239809147030","article-title":"A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression","volume":"10","author":"Fava","year":"1998","journal-title":"Ann Clin Psychiatry"},{"key":"2024032600050522700_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/00926239808414663","article-title":"Sexual dysfunction induced by serotonin reuptake antidepressants","volume":"24","author":"Labbate","year":"1998","journal-title":"J Sex Marital Ther"},{"key":"2024032600050522700_bib33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00004714-200104000-00006","article-title":"Effect of sexual function of long term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care","volume":"21","author":"Ekselius","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"2024032600050522700_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.289.1.56","article-title":"Treatment of antidepressant-associated sexual dysfunction with sildenafil: A randomized controlled trial","volume":"289","author":"Nurnberg","year":"2003","journal-title":"JAMA"},{"key":"2024032600050522700_bib35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1017\/S1092852900024433","article-title":"Selective phosphodiesterase type-5 inhibitor treatment of serotonergic reuptake inhibitor antidepressant-associated sexual dysfunction: A review of diagnosis, treatment, and relevance","volume":"8","author":"Nurnberg","year":"2003","journal-title":"CNS Spectr"},{"key":"2024032600050522700_bib36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00131746-200103000-00003","article-title":"Managing treatment-emergent sexual dysfunction associated with serotonergic antidepressants: Before and after sildenafil","volume":"7","author":"Nurnberg","year":"2001","journal-title":"J Psychiatr Pract"},{"key":"2024032600050522700_bib37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/01.gme.0000145876.76178.dc","article-title":"Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of The North American Menopause Society","volume":"11","author":"Na","year":"2004","journal-title":"Menopause"},{"key":"2024032600050522700_bib38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/01.GME.0000075502.60230.28","article-title":"The impact of hormones on menopausal sexuality: A literature review","volume":"11","author":"Bachmann","year":"2004","journal-title":"Menopause"},{"key":"2024032600050522700_bib39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01541610","article-title":"Perimenopausal sexuality","volume":"16","author":"Cutler","year":"1987","journal-title":"Arch Sex Behav"},{"key":"2024032600050522700_bib40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1592\/phco.21.5.464.34486","article-title":"Urogenital atrophy: Prevention and treatment","volume":"21","author":"Willhite","year":"2001","journal-title":"Pharmacotherapy"},{"key":"2024032600050522700_bib41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1471-0528.1996.tb09741.x","article-title":"A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy","volume":"103","author":"Ayton","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"2024032600050522700_bib42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00042192-200007030-00005","article-title":"17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis","volume":"7","author":"Rioux","year":"2000","journal-title":"Menopause"},{"key":"2024032600050522700_bib43","first-page":"316","article-title":"Hormones and sexuality: Effect of estrogen and progestogen","volume":"56","author":"Dennerstein","year":"1980","journal-title":"Obstet Gynecol"},{"key":"2024032600050522700_bib44","first-page":"3896","article-title":"The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life","volume":"84","author":"Barnhart","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032600050522700_bib45","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM200009073431002","article-title":"Transdermal testosterone treatment in women with impaired sexual function after oophorectomy","volume":"343","author":"Shifren","year":"2000","journal-title":"N Engl J Med"},{"key":"2024032600050522700_bib46","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00042192-200205000-00004","article-title":"The effects of tibolone on mood and libido","volume":"9","author":"Davis","year":"2002","journal-title":"Menopause"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515312698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515312698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/2\/Supplement_3\/154\/47521888\/jsm_2_supplement_3_154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/2\/Supplement_3\/154\/47521888\/jsm_2_supplement_3_154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:02:20Z","timestamp":1711414940000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/2\/Supplement_3\/154\/6862958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,1]]},"references-count":46,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2005,9,1]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2005.00131.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,9]]},"published":{"date-parts":[[2005,9,1]]}}}